Energy Healing for Fibromyalgia
Trial Summary
What is the purpose of this trial?
This study aims to study the clinical effects of Energy Healing using fMRI and determine its application to Fibromyalgia patients. We also want to find out how active Energy Healing compares to sham Energy Healing in terms of brain connectivity and pain interference scores.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but you should not introduce any new medications or treatments for fibromyalgia during the study. Also, you cannot use certain pain medications on the day of the MRI scan or 48 hours before it.
Is energy healing safe for humans?
How does the Energy Healing treatment differ from other treatments for fibromyalgia?
Energy Healing is unique because it focuses on balancing the body's energy fields, which is different from conventional treatments like medication or physical therapy that target physical symptoms directly. This approach is more aligned with complementary therapies such as acupuncture or meditation, which aim to enhance the body's natural healing processes.678910
Research Team
Richard Harris, PhD
Principal Investigator
UCI SSIHI
Eligibility Criteria
This trial is for women aged 18-75 with Fibromyalgia who meet the 2016 diagnostic criteria. Participants must not have MRI contraindications, agree to not start new treatments during the study, can travel to the site for sessions, and are proficient in English. They should experience a certain level of pain without pain-free days recently.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline assessments including fMRI and other measures before intervention
Intervention
Participants receive Energy Healing or sham Energy Healing
Follow-up
Participants are monitored for changes in pain severity, brain connectivity, and other exploratory outcomes
Treatment Details
Interventions
- Energy Healing
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor